News & Events

February 15, 2012

IntegriChain Delivers Pharmacy Level Inventory Metrics

PHARMA MANUFACTURERS WILL HAVE THE ABILITY TO REPORT PHARMACY INVENTORY LEVELS USING INTEGRICHAIN’S DNA INVENTORY: RETAIL SOLUTIONS

Princeton, NJ – February 15, 2012 – IntegriChain Inc., a commercial provider of data and analytic insights to the pharmaceutical industry, announced today the introduction of a new methodology for its DNA Inventory: Retail solution that adds the ability to report on independent and chain pharmacies’ inventory levels, by product NDC code, using actual un-projected data.

Historically, manufacturers have had visibility to wholesaler inventory and a handful of chain warehouses, but no way to directly measure inventory in the overall retail channel.

IntegriChain’s new methodology uses a combination of product “sell-in” data, product “returns” data, and actual pharmacy “point-of-sale” data to accurately calculate inventory levels in the downstream retail channel.

“The ability to align actual pharmacy purchases, sales and returns enables us to deliver a complete and timely view of inventory trends for our customers,” said Kevin Leininger, IntegriChain CEO. “Finance, forecasters and demand planners need forward channel visibility now more than ever. With blockbuster patent expirations and mounting supply shortages, retail inventory is key to sound business planning.”

Through the DNA Inventory: Retail solution, IntegriChain is now able to report an NDC’s total units, dollars and days of inventory present in retail distribution centers, stores, and morgues on a weekly basis.

According to Dan Kinney, IntegriChain VP of Information Services, IntegriChain customers are using DNA Inventory to “tighten their pipeline inventory reserves and improve their demand planning efficiency. The bottom line is to fill the highest possible percentage of orders while not tying up undue amounts of capital on the balance sheet.”

About IntegriChain
IntegriChain, Inc. launched the Demand Network Analytics (DNA) commerce platform in 2007. Today, DNA is helping a growing community of innovative manufacturers realize their vision of a truly demand driven enterprise. DNA’s trade data management and analytic applications optimize hundreds of billions of dollars in annual commerce, helping manufacturers lower their distribution costs, improve sales predictability, and ensure product availability throughout their distribution channels. For more information, please visit www.integrichain.com.

All names referred to are trademarks or registered trademarks of their respecitve owners.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand